Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

98.89
Delayed Data
As of 2:28pm ET
 +0.79 / +0.81%
Today’s Change
62.96
Today|||52-Week Range
153.99
-22.16%
Year-to-Date

Today’s Trading

Previous close98.10
Today’s open98.23
Day’s range97.95 - 99.58
Volume232,598
Average volume (3 months)1,022,259
Market cap$10.4B
Data as of 2:28pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)-13.15%
Earnings growth (this year)-30.41%
Earnings growth (next 5 years)+163.00%
Revenue growth (last year)+90.66%
P/E ratioNM
Price/Sales127.96
Price/Book5.82

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.08-0.16%
SGENSeattle Genetics Inc+0.06+0.11%
TSROTESARO Inc+0.17+0.35%
JAZZJazz Pharmaceuticals...-0.69-0.42%
Data as of 2:45pm ET, 05/24/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$1.78
Annual revenue (last year)$89.9M
Annual profit (last year)-$490.9M
Net profit margin-545.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts